Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?

PURPOSE OF REVIEW: In this article, we consider advanced technologies for the management of diabetes. RECENT FINDINGS: Specifically, we pose the question of which should come first: an insulin pump (CSII) or a continuous glucose monitor (CGM)? Historical perspective on both insulin delivery and gluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Christopher T., Criego, Amy B., Carlson, Anders L., Bergenstal, Richard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Therapies and New Technologies in the Treatment of Diabetes (M Pietropaolo, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597598/
https://www.ncbi.nlm.nih.gov/pubmed/31250124
http://dx.doi.org/10.1007/s11892-019-1177-7
Descripción
Sumario:PURPOSE OF REVIEW: In this article, we consider advanced technologies for the management of diabetes. RECENT FINDINGS: Specifically, we pose the question of which should come first: an insulin pump (CSII) or a continuous glucose monitor (CGM)? Historical perspective on both insulin delivery and glucose measurement is provided. Recently published clinical trials are reviewed. Practical issues including quality of life, patient education, and out-of-pocket cost are discussed. SUMMARY: Based on available evidence and clinical experience, we favor CGM as a first-line technology recommendation for the treatment of type 1 diabetes (T1D). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11892-019-1177-7) contains supplementary material, which is available to authorized users.

Ejemplares similares